Barclays analyst Lauren Lieberman maintained a Buy rating on Constellation Brands (STZ – Research Report) on July 1 and set a price target of $281.00. The company’s shares closed last Friday at $235.43.
According to TipRanks.com, Lieberman is a 3-star analyst with an average return of 2.1% and a 53.2% success rate. Lieberman covers the Consumer Goods sector, focusing on stocks such as International Flavors & Fragrances, Coca-Cola Europacific Partners, and The Estée Lauder Companies.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Constellation Brands with a $271.64 average price target, implying a 16.6% upside from current levels. In a report issued on June 16, Evercore ISI also reiterated a Buy rating on the stock with a $285.00 price target.
Constellation Brands’ market cap is currently $44.81B and has a P/E ratio of 38.34.
Based on the recent corporate insider activity of 38 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of STZ in relation to earlier this year. Most recently, in April 2022, Jeremy Fowden, a Director at STZ sold 7,574 shares for a total of $1,820,569.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Founded in 1945, Constellation Brands, Inc. is engaged in the production, marketing, and distribution of beer, wine, and spirits in the United States, Mexico, New Zealand, and Italy. The company’s iconic beer brands include Corona Extra, Corona Light, Corona Premier, Modelo Especial, Modelo Negra and Pacifico. Its premium wine and spirits brands include Robert Mondavi, Kim Crawford, Meiomi, The Prisoner, SVEDKA Vodka, Casa Noble Tequila and High West Whiskey.
Read More on STZ:
- Ansell (ANSLF) Gets a Buy Rating from Morgan Stanley
- Morgan Stanley Maintains a Buy Rating on Medibank Private Ltd. (MDBPF)
- Bell Potter Thinks Cogstate Ltd’s Stock is Going to Recover
- Analysts Offer Insights on Healthcare Companies: Ramsay Health Care (OtherRMSYF) and Paradigm Biopharmaceuticals Ltd. (OtherPBIGF)
- Jarden Reaffirms Their Buy Rating on Star Entertainment Group Limited (EHGRF)